Abbott Laboratories (ABT – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Larry Biegelsen from Wells Fargo maintained a Buy rating on ...

Citi reaffirmed its positive stance on Abbott Laboratories (NYSE:ABT), maintaining a Buy rating and a price target of $127.00. The endorsement follows updates from the company's management ...

The ABBOTT PRISM system is intended for in vitro diagnostic use only. A high throughput, highly automated test system for blood screening: The ABBOTT PRISM is a fully automated, high-volume blood ...

Citi reaffirmed its positive stance on Abbott Laboratories (NYSE:ABT), maintaining a Buy rating and a price target of $127.00. The endorsement follows updates from the company's management regarding ...

Ausria, a radioimmunoassay test to detect serum hepatitis, was launched in 1972 and marked the beginning of Abbott's immunodiagnostics business. A year later, the Abbott Diagnostics Division was ...

The prescription-free test you can take at home will help discern which respiratory virus you have, as symptoms often overlap ...